Kobercová E, Srba M, Fischer L (March 2023). "Sulfadiazine and phosphinothricin selection systems optimised for the transformation of tobacco BY-2 cells". Plant Cell Reports. 42 (3). Springer Science and Business Media LLC: 535–548. doi:10.1007/s00299-022-02975-7. PMID36609768. S2CID255501050.
drugs.com
"Sulfadiazine". The American Society of Health-System Pharmacists. Archived from the original on 20 December 2016. Retrieved 8 December 2016.
World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
nih.gov
pubmed.ncbi.nlm.nih.gov
"Sulfadiazine", LiverTox: Clinical and Research Information on Drug-Induced Liver Injury, Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases, 2012, PMID31643992, retrieved 2021-12-27
Kobercová E, Srba M, Fischer L (March 2023). "Sulfadiazine and phosphinothricin selection systems optimised for the transformation of tobacco BY-2 cells". Plant Cell Reports. 42 (3). Springer Science and Business Media LLC: 535–548. doi:10.1007/s00299-022-02975-7. PMID36609768. S2CID255501050.
ncbi.nlm.nih.gov
"Sulfadiazine", LiverTox: Clinical and Research Information on Drug-Induced Liver Injury, Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases, 2012, PMID31643992, retrieved 2021-12-27
semanticscholar.org
api.semanticscholar.org
Kobercová E, Srba M, Fischer L (March 2023). "Sulfadiazine and phosphinothricin selection systems optimised for the transformation of tobacco BY-2 cells". Plant Cell Reports. 42 (3). Springer Science and Business Media LLC: 535–548. doi:10.1007/s00299-022-02975-7. PMID36609768. S2CID255501050.
web.archive.org
"Sulfadiazine". The American Society of Health-System Pharmacists. Archived from the original on 20 December 2016. Retrieved 8 December 2016.